Aarti Drugs Q4 Results
- BSE: 524348
- NSE: AARTIDRUGS
- ISIN: INE767A01016
- Sector: Biotechnology & Drugs
BSE
388.00
-9.75 (-2.45%)
-9.75 (-2.45%)Volume11.72 K
Updated: Fri 8 May, 2026 | 15:29:42
NSE
387.90-9.75 (-2.45%)
-9.75 (-2.45%)Volume1.32 L
Updated: Fri 8 May, 2026 | 15:44:36
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Aarti Drugs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 598.32 | 564.62 | 17.62% | 547.76 | 9.23% |
| Depreciation/ Amortization | 14.88 | 17.95 | 7.80% | 13.58 | 9.57% |
| Operating Income | 78.44 | 37.09 | 63.66% | 72.22 | 8.61% |
| Net Income | 62.86 | 40.54 | 69.69% | 47.31 | 32.87% |
| Other Operating Expenses Total | 115.19 | 126.87 | -0.46% | 111.21 | 3.58% |
| Net Income Before Taxes | 71.15 | 29.02 | 40.17% | 64.18 | 10.87% |
| Total Revenue | 676.76 | 601.71 | 21.59% | 619.99 | 9.16% |
| Selling/ General/ Admin Expenses Total | 31.35 | 33.16 | 12.93% | 25.87 | 21.19% |
| Diluted Normalized EPS | 6.77 | 4.44 | 66.81% | 5.18 | 30.74% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.